期刊文献+

酶免疫──醋酸纤维薄膜电泳法诊断大肠癌 被引量:1

THE CLINICAL USEFULNESS OF TUMOR ASSOCIATED ANTIGENS DETECTION IN PATIENTS WITH COLORECTAL CANCER BY ELECTROPHORESIS AND ENZYME STAINING
下载PDF
导出
摘要 以抗结肠癌及胰腺癌的单克隆抗体用酶免疫──醋酸纤维薄膜电泳法,检测大肠癌及非癌疾病患者粪便中的癌相关抗原。其中大肠癌61例,慢性肠炎20例,正常人100例。结果表明,四株单克隆抗体CL-3、CL-4、PS-2、PS-9对应抗原在大肠癌患者粪便中的平均含量显著高于正常对照组及非癌肠道疾病组,其阳性率分别为75.4%、59.4%,72.5%和51.3%,如将三株单抗CL-3、CL-4、PS-2组合应用,则大肠癌组阳性率达86.2%,正常组为15.2%,肠炎组为16.6%,65例大肠癌中,5例早期诊断(DukesA期)患者均为阳性。本方法可能为早期诊断大肠癌提供简便省时,价廉,便于推广的新方法。 By monoclonal antibodies tumor-associated antigens were assayed by electrophoresis and immuno-enzyme staining methods in fecal extracts from patients with colorectal cancer and non-malignant diseases. The results indicated that the average content of tumor-associated antigens in colorectal cancer patients are significantly higer than those in normal individuals and in non-malignant diseases. The McAbs positive rates in colorectal cancer are:CL-3,74.5%;CL-459.5%;PS-2 72.5%and PS-9 51.3%, When detected by cocktail of those three McAbs CL-3, CL-4 and PS-2, the positive rate of colorectal cancer is 86.2%normal individuals is 15.2%and enteritis is 16.6%. Five cases of Dukes A stage are all positive. This method may be useful for early diagnosis and mass screening of colorectal cancer,and it is easy to handle,time saving,money saving,and painless for patients.
出处 《肿瘤》 CAS CSCD 北大核心 1994年第6期314-316,共3页 Tumor
关键词 单克隆抗体 粪便诊断 诊断 大肠肿瘤 Colorectal cancer Tumor-associated antigen Monoclonal antibody Diagnosis
  • 相关文献

同被引文献31

  • 1Shin S,Sung BJ,Cho YS,et al.An antiapoptotic protein human Survivin is a direct inhibitor of caspase-3 and caspase-7[J].Biochemistry,2001,40(4):1117.
  • 2Sarela AI,Macadam RC,Farmery SM,et al.Expression of the antiapoptosis gene,Survivin,predicts death from recurrent colorectal carcinoma[J].Gut,2000,46(5):645.
  • 3Hiroshi K,Masao T,Hisashi S,et al.Expression of Survivin correlates with apoptosis,proliferation and angiogenesis during human colorectal tumorigenesis[J].Cancer,2001,9(11):2026.
  • 4Danid E,Beck MD.Colorectal cancer Screening[J].Clin Color Rectal Surg,2001,14(2):115.
  • 5Yamamoto H,Miyake Y,Noura S,et al.Tumor markers for colorectal cancer[J].Gan To Kagaku Ryoho,2001,28:1299-1305.
  • 6Kuusela P,Haglund,Roberts PJ.Comparision of new tumor marker CA242 with CA19-9,CA50 and Carcinomabryonic antigen(CEA) Digestive tract disease[J].Br J Cancer,1997,63(4):636-640.
  • 7HO SB.Biochemical and other markers of colon cancer[J].Gastroenterol Clin Nor Am,1988,17:811-830.
  • 8Rothlin MA,Joller H,Largiader F,et al.CA242 in a new tumor marker for pancreatic cancer[J].Cancer,1993,71 (3):701-707.
  • 9Reiter W,Stieber P,Reuter C,et al.Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer[J].Anticancer Res,2000,20:5195-5198.
  • 10Holubee LJ,Toplocan O,Pikner R,et al.The significance of CEA,CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence[J].Anticancer Res,2000,20:5237-5244.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部